Casein Glycomacropeptide in Active Distal Ulcerative Colitis (Pilot Study)

NCT01534312 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Colitis, Ulcerative
Inflammatory Bowel Diseases

Interventions

DRUG: CGMP protein
DRUG: Maximal oral 5ASA

Sponsor

University of Aarhus

Collaborators

[object Object]